The Effects of 8-week Resistance and Aerobic Exercise on Anxiety, Depression, Sleep, Inhibitory Control in Young Adults With Smartphone Overdependence

Not Applicable

Completed

• Conditions: Exercise; Smartphone Addiction; Sleep; Inhibition; Mood

• Registration Number: NCT06848322
• Lead Sponsor: University of Seoul

Brief Summary

The purpose of this study is to identify the effects of the resistance exercise and aerobic exercise on depression, anxiety, sleep, inhibitory control in young adult with smartphone overdependence

Detailed Description

Not available

Study Timeline

• Study Start: 2025-01-06
• Status Verified: 2025-02
• Primary Completion: 2025-02-04
• Study Completion: 2025-02-05
• Study First Submitted: 2025-02-09
• Study First Submitted QC: 2025-02-21
• Last Update Submitted: 2025-02-21
• Study First Posted: 2025-02-27
• Last Update Posted: 2025-02-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 36

Inclusion Criteria

• Smartphone overdependent scale score of 24 ≥
• No regular exercise in the past 3 months

Exclusion Criteria

• Unable to perform exercise
• Patients with musculoskeletal disorders
• Patients with cardiovascular diseases.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
sleep duration	pre intervention: for 8days(before the intervention) / post intervention: for 8days(after the intervention)	In this study, we will assess participants' sleep duration using a wrist-worn GENEActiv triaxial accelerometer (Activinsights, Cambridge, UK). Participants will be instructed to wear the device on their non-dominant wrist 24 hours a day for 8 days, except during contact sports that may pose a risk of injury. Sleep duration (minutes) is defined as the total time spent sleeping.
Sleep efficiency	pre intervention: for 8days(before the intervention) / post intervention: for 8days(after the intervention)	In this study, we will assess participants' sleep efficiency using a wrist-worn GENEActiv triaxial accelerometer (Activinsights, Cambridge, UK). Participants will be instructed to wear the device on their non-dominant wrist 24 hours a day for 8 days, except during contact sports that may pose a risk of injury. Sleep efficiency(%) is defined as the proportion of time spent asleep relative to time in bed
Time in bed	pre intervention: for 8days(before the intervention) / post intervention: for 8days(after the intervention)	In this study, we will assess participants' time in bed using a wrist-worn GENEActiv triaxial accelerometer (Activinsights, Cambridge, UK). Participants will be instructed to wear the device on their non-dominant wrist 24 hours a day for 8 days, except during contact sports that may pose a risk of injury. Time in bed (minutes) is defined as the total time spent in bed, including both sleep and wakefulness
Sleep onset time	pre intervention: for 8days(before the intervention) / post intervention: for 8days(after the intervention)	In this study, we will assess participants' sleep onset time using a wrist-worn GENEActiv triaxial accelerometer (Activinsights, Cambridge, UK). Participants will be instructed to wear the device on their non-dominant wrist 24 hours a day for 8 days, except during contact sports that may pose a risk of injury. Sleep onset time (hours and minutes) is defined as the time at which sleep begins.
wake time	pre intervention: for 8days(before the intervention) / post intervention: for 8days(after the intervention)	In this study, we will assess participants' sleep onset time using a wrist-worn GENEActiv triaxial accelerometer (Activinsights, Cambridge, UK). Participants will be instructed to wear the device on their non-dominant wrist 24 hours a day for 8 days, except during contact sports that may pose a risk of injury. Wake time (hours and minutes) is defined as the final wake-up time.

Secondary Outcome Measures

Name	Time	Method
Depression	pre intervention(day 1), post intervention(day 57)	Participants will visit the laboratory to complete the Beck Depression Inventory(BDI), a self-reported questionnaire assessing depressive symptoms. The BDI consists of 21 items, each scored on a scale from 0 to 3, with total scores ranging from 0 to 63. Higher scores indicate more severe depressive symptoms
Anxiety	pre intervention(day 1), post intervention(day 57)	Participants will visit the laboratory to complete the Beck Anxiety Inventory (BAI), a self-reported questionnaire assessing anxiety symptoms. The BAI consists of 21 items, each scored on a scale from 0 to 3, with total scores ranging from 0 to 63. Higher scores indicate more severe anxiety symptoms.
Inhibition	pre intervention(day 1), post intervention(day 57)	The Go/NoGo task will be used to measure the inhibition The measured variables will include reaction time (RT) and accuracy.; At the beginning of the test, a series of stimulus characters will be presented in the center of the screen one by one. Each stimulus character will be displayed for 400 ms, with a random interval of 400-700 ms between stimuli.; Before the test, participants will be informed that "L" is a Go stimulus and "C" is a NoGo stimulus. When "L" appears in the center of the screen, participants will be required to press the space bar key with their index finger as quickly and accurately as possible. When "C" appears, participants must not respond.; The system will record the reaction time and accuracy for Go stimuli and the accuracy for NoGo stimuli. The total number of stimulus characters will be 240, consisting of 180 Go stimuli (75%) and 60 NoGo stimuli (25%).

Trial Locations

Locations (1)

University of Seoul, Centennial Memorial Hall.; 🇰🇷 Dongdaemun, Seoul, Korea, Republic of

University of Seoul, Centennial Memorial Hall.

🇰🇷Dongdaemun, Seoul, Korea, Republic of